A K-1 with near zero depreciation in year three of a medical office fund deserves a harder look than the sponsor usually gives it
Passive investors in medical office funds generally expect the first few K-1s to carry meaningful depreciation. A cost segregation study in year one, with bonus depreciation flowing through and a paper loss that offsets other passive income, is the pattern most LP positions follow. So it is worth pausing when one position breaks that pattern. Take a 2021 vintage MOB fund holding 68,000 square feet across two suburban buildings, say in a Nashville submarket, where the 2023 K-1 shows essentially no depreciation and the prior two years looked the same. A sponsor in that spot will often say the properties are held for investment under a long term basis schedule and that the depreciation profile normalizes over time. Anyone who has read enough K-1s knows that answer is not an answer. A CPA looking at that fact pattern will usually land on one of two explanations. Either the cost segregation study was never done, or it was done and produced almost nothing, which happens with older buildings when a prior owner has already burned through the accelerated components. Buildings of 1998 and 2003 vintage fit that profile. The harder question is whether the sponsor owed disclosure before capital was wired. PPM language such as depreciation benefits available to investors reads like a promise and functions like nearly nothing. It commits the sponsor to no specific number and no specific method, and most subscription documents give an investor nothing firmer to point to. I would like to hear from anyone who has seen flat or near zero depreciation in years two and three of a MOB fund, and whether they were able to get anything from the sponsor beyond reassurance.